Swine Flu - H1N1 influenza - Biotech, Pharma and Life Science Channel
Swine flu is the common name given to a relatively new strain of influenza (flu) that caused a flu pandemic in 2009-2010.
It is also referred to as H1N1 influenza (because it is the H1N1 strain of virus).
The H1N1 flu virus will be one of the main viruses circulating this winter. Therefore, in the UK the H1N1 flu virus has been included in the 2010-11 seasonal flu vaccine.
Vaccination
It is recommended that people in high-risk groups be vaccinated against H1N1 (swine flu). This includes all pregnant women, at any stage of pregnancy.
What to do if you have H1N1 flu
People with H1N1 flu typically have a fever or high temperature (over 38C or 100.4F) and may also have aching muscles, sore throat or a dry cough. If you show two or more of the following symptoms, you may have H1N1 flu:
* unusual tiredness
* headache
* runny nose
* sore throat
* shortness of breath or cough
* loss of appetite
* aching muscles
* diarrhoea or vomiting
The symptoms are very similar to other types of seasonal flu. Most people recover within a week, even without special treatment.
If you think you have H1N1 flu, see your own qualified medical practitioner. They will decide the most appropriate action to take.
High-risk groups
Some people are more at risk of complications if they catch flu. People are particularly vulnerable if they have:
* chronic (long-term) lung disease
* chronic heart disease
* chronic kidney disease
* chronic liver disease
* chronic neurological disease (neurological disorders include motor neurone disease, multiple sclerosis and Parkinson's disease)
* immunosuppression (whether caused by disease or treatment)
* diabetes mellitus
Also at risk are:
* patients who have had drug treatment for asthma in the past three years
* pregnant women
* people aged 65 and over
News Articles
New SARS-Like Coronavirus Suspected at New York Hospital
LONG BEACH, CA -- (Marketwired) -- 05/18/13 -- AvianFluTalk.com, an online discussion forum created in 2005 to track the potential threat of an avian flu pandemic, has been the venue for a serious di...
Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results
BEIJING, May 17, 2013 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of vaccines in China, today announced that it will release its unaudited financial results for the...
A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing
SINGAPORE and ZURICH, May 17, 2013 /PRNewswire/ -- Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy vol...
MEDFORD, N.Y., May 16, 2013 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, announces that the Company has enter...
Research Team Publishes New Methods for Synthetic Generation of Influenza Vaccines
LA JOLLA, Calif. and ROCKVILLE, Md., May 15, 2013 /PRNewswire/ -- A team of international researchers from the J. Craig Venter Institute (JCVI), Synthetic Genomics Inc. (SGI), Novartis Vaccines a...
Sinovac Appoints Ernst & Young Hua Ming Llp China as External Auditor
BEIJING, May 15, 2013 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, has appointed China-based Ernst & Young Hua Ming LLP as...
Sinovac Presents at the UBS Global Healthcare Conference in May 2013
BEIJING, May 14, 2013 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that management is scheduled to present at...
NES ZIONA, Israel, May 13, 2013 /PRNewswire/ -- NanoPass Technologies Ltd. ("NanoPass"), a pioneer in intradermal (into-the-skin or ID) vaccine delivery solutions, is collaborating with the US Center...
NanoViricides, Inc. Brings in Experienced Executive as Interim CFO
NanoViricides, Inc. (OTC BB: NNVC) (the "Company") announced today that it has retained Ms. Meeta Vyas, a successful former CEO of a public company with significant experience...
CEL-SCI Corporation Reports Second Quarter 2013 Financial Results
CEL-SCI Corporation (NYSE MKT: CVM) reports financial results for the fiscal quarter ended March 31, 2013. CEL-SCI reported that net loss available to common shareholders...
Events
None
Companies
The International Society for Interferon and Cytokine Research (ISICR), based in Bethesda, Md., is a non-profit organization devoted to interferon, cytokine and chemokine r...
Taiga Biotechnologies, Inc. is a biotech company based in Aurora, CO. The companyâs mission is to develop novel approaches to complex diseases, including cancers, immunodefic...
Mollen Immunization Clinics is one of the largest and most trusted providers of immunizations in the United States. Mollen conducts a network of seasonal flu shot clinics at drug...
Okairos is a clinical-stage biopharmaceutical company, developing genetic vaccines for major infectious diseases - including malaria, hepatitis C, influenza, respiratory syncytial...
PaxVax is a privately held company established in 2007 to develop and commercialize innovative and socially responsible vaccines against infectious diseases. PaxVax has a clinical...
Gemmus is a privately held biotechnology company focused on the development of innovative pharmaceutical products for the treatment of infectious diseases by modulating the host r...
Visterra discovers and develops novel drugs for the prevention and treatment of major diseases. The companyâs proprietary platform generates unique structural information tha...
Visterra discovers and develops novel drugs for the prevention and treatment of major diseases. The companyâs proprietary platform generates unique structural information tha...
PaxVax is a privately held company committed to developing better vaccines to better the world. Established in 2007, PaxVax has a clinical-stage product portfolio, including a cho...
NanoViricides, Inc. (www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials for viral therapy. The Company's novel nanoviricid...
Clinical Trials
Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy
Background: - Drugs given to treat cancer (chemotherapy) can weaken the human immune system. But it can also become weaker because of aging. Interleukin (IL)-7, a molecule produced natura...
The hypothesis for this trial is that the incidence of a pre-defined composite of common systemic hypersensitivity adverse events for Flublok recipients is non-inferior to that reported fo...
Influenza Vaccine in Lung Transplant Patients
Research Question: How do antibody and T cell responses following influenza vaccine compare among lung transplant patients, patients waiting for lung transplantation and healthy individua...
Prevention of Respiratory Infections and MAnagement Among Children (PRIMAKid)
The PRIMAKid trial is a general practice based double-blind randomized placebo-controlled trial on the effectiveness and costs of combined influenza and pneumococcal vaccination in pre-sch...
Endothelial Modulation for Angiogenic Therapy
Coronary artery disease is the single most important killer of Canadians. Despite major advances in therapy, there is still a significant proportion of patients identified with the disease...
FLU-VACS Comparative Study in Adults
The purpose of this study is to compare 2 licensed flu vaccines to each other and to placebo (inactive substance). The study will be conducted among healthy adult participants aged 18-49 y...
This study is evaluating the safety and immunogenicity of GSK Biologicals' Hib-MenCY-TT vaccine compared to a control group receiving licensed Hib conjugate vaccine, each administered at 2...
Immune Response to Influenza Vaccine in HIV-Infected Individuals
This study will evaluate how HIV infection, including CD4 cell count and viral load, affects the patient's ability to produce antibodies in response to vaccination with the influenza (flu)...
This investigation is a sub-study of the 6-year multinational ESPRIT (Evaluation of Subcutaneous Proleukin in a Randomized International Trial) protocol. It will compare the effectiveness...
Influenza Vaccine in HIV Infection: Immune Response and Effect on Viral Load
This 2-part study will examine 1) the immune response to influenza (flu) vaccine in HIV-infected patients, and 2) the effect of flu vaccine on HIV viral loads. Earlier studies have shown t...
PubMed Articles
Xiao-Qing-Long-Tang (XQLT, TJ-19, Sho-seiryu-to, so-cheong-ryong-tang) has been used against acute airway diseases for thousands of year in ancient China. Most of the acute airway illnesses are caused...
An immunochromatographic strip method, developed with the excretory-secretory antigens from muscle larvae (ML) of Trichinella spiralis labeled with colloidal gold, was used for the detection of anti-T...
Trichinella infection in Serbia in the first decade of the twenty-first century.
In Serbia, infection with Trichinella spp. has been recognized as a human health and animal husbandry problem for almost a century. The rate of swine infection gradually decreased from 0.14% to 0.02%...
Survey of Trichinella infections in domestic pigs from northern and eastern Henan, China.
The aim of this work was to investigate the current situation of Trichinella infections in swine in the cities of Anyang and Shanqiu in the Henan province historically designated as trichinellosis-fre...
Although intestinal flora are crucial in maintaining immune homeostasis of the intestine, the role of intestinal flora in immune responses at other mucosal surfaces remains less clear. Here, we show t...
Receptor binding by a ferret-transmissible H5 avian influenza virus.
Cell-surface-receptor binding by influenza viruses is a key determinant of their transmissibility, both from avian and animal species to humans as well as from human to human. Highly pathogenic avian...
Global concerns regarding novel influenza A (H7N9) virus infections.
Human infection with a novel avian-origin influenza A (H7N9) virus.
Infection of poultry with influenza A subtype H7 viruses occurs worldwide, but the introduction of this subtype to humans in Asia has not been observed previously. In March 2013, three urban residents...
Recently, a novel reassortant virus, influenza A(H3N2)v [A(H3N2)v], was identified as the causative pathogen in 307 human cases of influenza in the United States. A(H3N2)v contains the matrix gene fro...
SUMMARY It is unknown which intervention strategies are used or effective to increase influenza vaccine uptake by healthcare workers (HCWs) in acute hospitals in England. We undertook a survey in acut...
Videos
H1N1 Influenza (Gripe porcina) (Swine Flu)
En este video, Ana Rivera, Asesor de Salud Publica para los CDC, describe la influenza o gripe porcina: sus signos y síntomas, cómo se transmite, los medicam...
Medical and Biotech [MESH] Definitions
Sus Scrofa
A species of SWINE, in the family Suidae, comprising a number of subspecies including the domestic pig Sus scrofa domestica.
Brucella Suis
A species of gram-negative bacteria, primarily infecting SWINE, but it can also infect humans, DOGS, and HARES.
Taenia Solium
Species of tapeworm in the genus TAENIA, that infects swine. It is acquired by humans through the ingestion of cured or undercooked pork.
Leptospira Interrogans Serovar Pomona
A serovar of the bacterial species LEPTOSPIRA INTERROGANS, whose primary hosts include CATTLE and SWINE.
Haemophilus Parasuis
A species of gram-negative bacteria in the genus HAEMOPHILUS found, in the normal upper respiratory tract of SWINE.
